Guidance in author instructions of hematology and oncology journals: A cross sectional and longitudinal study.

TitreGuidance in author instructions of hematology and oncology journals: A cross sectional and longitudinal study.
Publication TypeJournal Article
Year of Publication2017
AuthorsToews, I, Binder, N, Wolff, RF, Toprak, G, von Elm, E, Meerpohl, JJ
JournalPLoS One
Volume12
Issue4
Paginatione0176489
Date Published2017
DOI10.1371/journal.pone.0176489
ISSN1932-6203
Abstract

BACKGROUND: The debate about the value of biomedical publications led to recommendations for improving reporting quality. It is unclear to what extent these recommendations have been endorsed by journals. We analyzed whether specific recommendations were included in author instructions, which journal characteristics were associated with their endorsement, how endorsement of the domains changed and whether endorsement was associated with change of impact factor between 2010 and 2015.

METHODS: We considered two study samples consisting of "Hematology" and "Oncology" journals of the Journal Citation Report 2008 and 2014, respectively. We extracted information regarding endorsement of the (1) recommendations of the International Committee of Medical Journal Editors, of (2) reporting guidelines, (3) requirement for trial registration and (4) disclosure of conflicts of interest. Data extraction was done by reading the author instructions before conducting a text search with keywords. We calculated a global generalized linear mixed effects model for endorsement of each of the four domains followed by separate multivariable logistic regression models and a longitudinal analysis. We defined endorsement as the author instructions saying that they approve the use of the recommendations.

RESULTS: In 2015, the ICMJE recommendations were mentioned in author instructions of 156 journals (67.5%). CONSORT was referred to by 77 journals (33.3%); MOOSE, PRISMA, STARD and STROBE were referred to by less than 15% of journals. There were 99 journals (42.9%) that recommended or required trial registration, 211 (91.3%) required authors to disclose conflicts of interest. Journal impact factor, journal start year and geographical region were positively associated with endorsement of any of the four domains. The overall endorsement of all domains increased between 2010 and 2015. The endorsement of any domain in 2010 seemed to be associated with an increased impact factor in 2014.

CONCLUSION: Hematology and oncology journals endorse major recommendations to various degrees. Endorsement is increasing slowly over time and might be positively associated with the journals' impact factor.

Alternate URL

http://www.ncbi.nlm.nih.gov/pubmed/28453528?dopt=Abstract

Alternate JournalPLoS ONE
Citation Key / SERVAL ID7768
Peer reviewRefereed
PubMed ID28453528
PubMed Central IDPMC5409080
                         

IUMSP | www.iumsp.ch
Institut universitaire de médecine sociale et préventive
Route de la Corniche 10, 1010 Lausanne - Switzerland
+41 21 314 72 72 | iumsp@chuv.ch

Go to top